Variation in geographical treatment intensity affects survival of non-small cell lung cancer patients in England
Daniela Tataru(NHS Digital), Margreet Lüchtenborg(London Cancer), Katie Spencer(University of Leeds), Michael Lind(University of Hull), Michael Peake(University of Leicester), Ruth H. Jack(Public Health England), Andrzej Wieczorek(Hull and East Yorkshire Hospitals NHS Trust), Andrew Bates
Cited by 25
Related Papers
Lung adenocarcinoma promotion by air pollutants
|Nature|2023|751
The expanding role of primary care in cancer control
|The Lancet Oncology|2015|544
The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients
|British Journal of Dermatology|2018|235
Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation
|JHEP Reports|2021|69
Prevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies
|JACC CardioOncology|2022|54